Trupanion (NASDAQ:TRUP) Director Sells 6,537 Shares of Company Stock

Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) Director Murray Low sold 6,537 shares of the firm’s stock in a transaction that occurred on Tuesday, November 10th. The stock was sold at an average price of $34.21, for a total transaction of $223,630.77. Following the completion of the transaction, the director directly owned 147,997 shares of the company’s stock, valued at approximately $5,062,977.37. This trade represents a 4.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Trupanion Stock Performance

TRUP stock traded down $0.06 during midday trading on Thursday, reaching $34.30. 241,698 shares of the company’s stock traded hands, compared to its average volume of 463,336. The company has a 50-day moving average price of $27.61 and a two-hundred day moving average price of $26.73. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.74 and a current ratio of 1.74. Trupanion, Inc. has a 52 week low of $21.16 and a 52 week high of $39.61. The firm has a market capitalization of $1.48 billion, a PE ratio of 56.23, a price-to-earnings-growth ratio of 1.59 and a beta of 1.27.

Trupanion (NASDAQ:TRUP – Get Free Report) last posted its earnings results on Thursday, November 5th. The financial services provider reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.04. Trupanion had a return on equity of 6.71% and a net margin of 1.71%. The firm had revenue of $405.59 million for the quarter, compared to the consensus estimate of $402.53 million. During the same quarter in the prior year, the business posted $0.13 earnings per share. As a group, equities analysts anticipate that Trupanion, Inc. will post 0.68 EPS for the current year.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on TRUP shares. Cantor Fitzgerald boosted their price objective on Trupanion from $30.00 to $33.00 and gave the company a “neutral” rating in a research note on Monday. Stifel Nicolaus raised their target price on Trupanion from $29.00 to $34.00 and gave the stock a “hold” rating in a research note on Monday. Atlantic Securities set a $42.00 target price on Trupanion in a report on Wednesday, July 15th. Zacks Research lowered Trupanion from a “strong-buy” rating to a “hold” rating in a report on Monday, August 24th. Finally, Wall Street Zen upgraded Trupanion from a “hold” rating to a “buy” rating in a research report on Saturday, November 7th. One research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $40.00.

Get Our Latest Analysis on Trupanion

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. BlackRock Inc. purchased a new position in shares of Trupanion during the 2nd quarter valued at $134,774,000. Bank of America Corp DE purchased a new stake in shares of Trupanion in the second quarter worth $14,262,000. Renaissancere Holdings Ltd. purchased a new stake in shares of Trupanion in the second quarter worth $6,514,510. Bank of New York Mellon Corp purchased a new stake in shares of Trupanion in the second quarter worth $4,631,000. Finally, Kopion Asset Management LLC raised its position in shares of Trupanion by 30.9% in the second quarter. Kopion Asset Management LLC now owns 522,999 shares of the financial services provider’s stock worth $12,955,000 after buying an additional 123,308 shares in the last quarter.

Trupanion Company Profile

(Get Free Report)

Trupanion provides medical insurance for cats and dogs, offering coverage for eligible veterinary care. Its products are designed to help pet owners manage unexpected costs from illnesses and injuries, subject to policy terms and exclusions. The company also provides software and payment services that enable participating veterinary practices to submit claims and receive payments directly, reducing the need for customers to pay covered costs upfront and seek reimbursement. Founded in 2000 and headquartered in Seattle, Trupanion serves customers in the United States and Canada.

Read More

Insider Buying and Selling by Quarter for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.